Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
calcipotriol, Quantity: 50 microgram/g
LEO Pharma Pty Ltd
Calcipotriol
Ointment
Excipient Ingredients: disodium edetate; dibasic sodium phosphate dihydrate; dl-alpha-tocopherol; liquid paraffin; steareth-2; propylene glycol; purified water; white soft paraffin
Topical
15, 30, 100g
(S4) Prescription Only Medicine
Calcipotriol ointment is indicated for the topical treatment of chronic stable plaque type psoriasis vulgaris in adult patients. INDICATIONS AS AT 26 MARCH 2002: DAIVONEX ointment is indicated for the topical treatment of chronic stable plaque type psoriasis vulgaris in adults and children (see Use in Children). In adult patients, DAIVONEX ointment may also be used in combination with either phototherapy, or systemic acitretin or cyclosporin.
Visual Identification: Translucent, white to yellowish ointment.; Container Type: Tube; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1994-04-26
Version 4.0 1 PRODUCT INFORMATION DAIVONEX ® OINTMENT Calcipotriol 50 microgram/g AUST R 46683 NAME OF THE MEDICINE: CALCIPOTRIOL Chemical structure of calcipotriol Chemical name: (1S, 3R, 5Z, 7E, 22E, 24S) -24-Cyclopropyl-9, 10-secochola-5,7,10(19), 22- tetraene-1,3,24-triol. CAS 112965-21-6 DESCRIPTION Calcipotriol is a white or almost white crystalline substance. It is freely soluble in ethanol, soluble in chloroform and propylene glycol, particularly insoluble in liquid paraffin. Solubility in water is 0.6 m g/mL and the melting point is 166 – 168ºC. Calcipotriol is a vitamin D derivative and behaves in a similar manner to vitamin D, forming a reversible temperature-dependent equilibrium between calcipotriol and pre-calcipotriol. DAIVONEX ® Ointment contains the anhydrous form of calcipotriol. It also contains dl- Į - tocopherol, disodium edetate, sodium phosphate - dibasic dihydrate, purified water, liquid paraffin, steareth-2, propylene glycol and soft white paraffin. PHARMACOLOGY Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol exhibits a vitamin D-like effect by competing for the 1,25(OH) 2 D 3 receptor. Calcipotriol is as potent as 1,25(OH) 2 D 3 , the naturally occurring active form of vitamin D, in regulating cell proliferation and cell differentiation, but much less active than 1,25(OH) 2 D 3 in its effect on calcium metabolism. Calcipotriol induces differentiation and suppresses proliferation (without any evidence of a cytotoxic effect) of keratinocytes, thus reversing the abnormal keratinocyte changes in psoriasis. The therapeutic goal envisaged with calcipotriol is thus a normalisation of epidermal growth. Pharmacokinetics: Pharmacokinetic studies with 3 H-calcipotriol have been performed in rats and minipigs. Oral absorption of calcipotriol was approximately 60% in rats and 40% in minipigs. The half-life of calcipotriol was 12 minutes in rats and 60 minutes in minipigs. The major metabolite of calcipotriol, MC1080, was present in the first plasma samp Przeczytaj cały dokument